
Sanjay Goel - University at Albany
Sanjay Goel is a Professor in the School of Business at the University at Albany, SUNY (UAlbany). He is also the Director of Research at the New York State Center for Information …
Sanjay Goel, MD, MS - Rutgers Cancer Institute of New Jersey
Sanjay Goel, MD, M.S. is an attending physician and a Professor of Medicine at Rutgers Cancer Institute of New Jersey. He received his medical degree from Christian Medical College, …
Sanjay Goel - Google Scholar
Sanjay Goel. Professor and Burwell Chair in Entrepreneurship, University of North Dakota. Verified email at und.edu. Articles Cited by Public access. Title. Sort. ... S Goel, W …
Sanjay Goel, School of Business, UAlbany - University at Albany
This is the website for Sanjay Goel, Associate Professor in the Information Technology Management Department of the School of Business, UAlbany
Sanjay Goel, School of Business, UAlbany - University at Albany
Sanjay Goel is an Associate Professor in the Information Technology Management Department (School of Business) at the University at Albany, SUNY. He is also the Director of Research at …
Sanjay Goel, MD, MS | Robert Wood Johnson Medical School
Sanjay Goel, MD, MS Professor and Director of Phase I/Investigational Therapeutics [email protected] Department(s) Medicine
Sanjay Goel - University of North Dakota
Sanjay Goel. Professor and Burwell Chair in Entrepreneurship, Entrepreneurship & Management
Sanjay Goel - Google Scholar
Examining Engineering Education through Bloom's Taxonomy. BY Andrew Barry, Tamsin Bolton, Marcia Jenneth Epstein, Sanjay Goel, Jill ... An overview of selected theories about student …
Sanjay Goel - Associate Professor - University at Albany, State ...
2024年12月18日 · Professor and Chair Information Security and Digital Forensics at University at Albany, SUNY · Experience: University at Albany, State University of New York · Location: …
- 职位: Professor and Chair …
- 位置: University at Albany, State University of New York
- 人脉数: 184
Sanjay Goel - Rutgers Health
Dr. Goel is the Director of Phase I Therapeutics at Rutgers Cancer Institute. He has an interest in drug development of anti-cancer agents, and development of biomarkers of drug response. He …